Is Open Evidence HIPAA Compliant? Everything You Need to Know

Overview of HIPAA Compliance

“HIPAA compliant” is not a static product label. Compliance depends on how you configure and use a service, whether a Business Associate Agreement (BAA) is in place, and if the platform’s safeguards satisfy the HIPAA Privacy Rule and HIPAA Security Rule. For Covered Entities and their Business Associates, the decisive question is whether the vendor will sign a BAA and operate within your organization’s risk management program.

Applied to Open Evidence, the safe rule of thumb is: do not input Protected Health Information (PHI) unless a BAA is executed and the deployment enforces appropriate administrative, physical, and technical controls. If you use the tool without PHI (or with properly de-identified data), HIPAA obligations are different but your internal policies still apply.

Because vendor features evolve, you should corroborate current capabilities through documentation, security questionnaires, and a formal compliance audit or assessment. This guidance is informational and not legal advice.

Business Associate Agreement Details

You need a BAA when Open Evidence will create, receive, maintain, or transmit PHI for you. If the tool is used only with de-identified data (as defined by HIPAA) or for general literature review without PHI, a BAA may not be required—confirm with counsel.

Key provisions to require

• Permitted uses and disclosures: Explicitly limit use of PHI to your purposes; prohibit secondary use such as model training or analytics unless you approve.
• Security safeguards: Reference the HIPAA Security Rule, encryption requirements, access controls, audit logging, and vulnerability management.
• Subcontractors: Require flow-down BAAs and transparency on subprocessors.
• Breach notification: Define timelines, incident reporting details, and cooperation duties.
• Return/Deletion: Ensure secure return or destruction of PHI at termination and upon request.
• Access and accounting: Support requests for access, amendments, and accounting of disclosures under the HIPAA Privacy Rule.
• Data location and retention: Specify storage regions, backups, and retention windows.
• Verification: Permit security reviews and request recent compliance audit artifacts (e.g., SOC 2 Type II, HITRUST, or equivalent reports).

Red flags to investigate

• Refusal to sign a BAA when PHI is in scope.
• Vague Data Sharing Policies or unrestricted “product improvement” rights.
• Indefinite retention of PHI or inability to delete data promptly.
• Use of advertising trackers or non-essential analytics on authenticated workflows handling PHI.

Data Privacy and Security Measures

Ask how Open Evidence implements HIPAA Security Rule safeguards across administrative, physical, and technical domains, and validate them in practice.

Administrative safeguards

• Risk analysis and risk management tailored to HIPAA.
• Policies for access, minimum necessary, incident response, and workforce training.
• Vendor management with documented BAAs for all subprocessors.

Technical safeguards

• Encryption in transit and at rest, with strong key management.
• Role-based access control, SSO/MFA, IP allowlists, and session timeouts.
• Comprehensive audit logs of access, admin actions, and data exports.
• Configurable data retention and deletion, including conversation-level purge.
• Data loss prevention (DLP) and prompt/response filtering to reduce PHI leakage.
• Secure SDLC, penetration testing, and regular third-party compliance audit activities.

Privacy Rule alignment

• Minimum necessary handling and de-identification where feasible.
• Clear user controls for PHI access, correction, export, and deletion.
• Prohibition of model training on your PHI without explicit consent in the BAA.

Third-Party Data Sharing Concerns

Modern AI and research platforms often rely on cloud providers, model APIs, content delivery networks, telemetry tools, and journal indexing services. Each third party can become a subprocessor with potential exposure to PHI if your prompts or uploads include it.

Due diligence essentials

• Request a complete, current subprocessor list and corresponding BAAs.
• Review Data Sharing Policies for data flows, retention periods, and cross-border transfers.
• Confirm that prompts, attachments, and conversation metadata are not used for training by any third party.
• Disable non-essential analytics and trackers in PHI-handling contexts.
• Validate TLS termination points, key custody, and isolation between tenants.

Integration with Medical Journals

Open Evidence’s value comes from surfacing peer-reviewed research. Journal integration typically involves APIs, content licensing, and search indices. While literature retrieval itself does not require PHI, how you query the system matters: avoid embedding identifiers in search prompts, citation notes, or file names.

Ask whether the platform caches articles or abstracts, where caches live, and how they are purged. If the tool builds embeddings or a knowledge graph from your uploads, ensure PHI is either excluded or handled within a HIPAA-eligible environment with strict access controls and retention limits.

User Control Over Protected Health Information

Strong user controls help you meet Privacy Rule obligations and internal governance standards. Confirm the following capabilities before using PHI:

• Granular deletion: Remove specific conversations, files, and derived artifacts.
• Retention controls: Set organization-wide defaults (including zero-retention for sensitive prompts).
• Access management: RBAC, least-privilege roles, and segregated workspaces or tenants.
• Export: Retrieve logs and records needed for investigations or accounting of disclosures.
• Visibility: Admin dashboards for monitoring usage, anomalies, and data egress.

Recommendations for Healthcare Providers

• Decide your use cases first (with/without PHI) and document the minimum necessary data elements.
• Do not input PHI until a BAA is executed and the HIPAA-eligible deployment is confirmed.
• Run a structured security review: architecture diagrams, subprocessor list, Data Sharing Policies, and recent compliance audit reports.
• Configure security: SSO/MFA, RBAC, retention limits, DLP rules, and restricted exports.
• Train users on safe prompting and de-identification; prohibit identifiers in research queries.
• Pilot with synthetic or de-identified data; verify logs and deletion controls work as promised.
• Monitor and audit: capture access logs, review anomalous activity, and rehearse incident response.
• Reassess annually or upon material product changes, and update your risk register accordingly.

Bottom line: You can use Open Evidence responsibly if you align its deployment with HIPAA requirements—secured configuration, a signed BAA, disciplined workflows, and ongoing oversight. Without those guardrails, treat the platform as unsuitable for PHI.

FAQs.

What is OpenEvidence's approach to HIPAA compliance?

Vendors typically offer a HIPAA-eligible deployment when they can sign a BAA, restrict data use, and implement Security Rule safeguards. Confirm OpenEvidence’s current approach by requesting its security whitepaper, subprocessor list, and recent audit results, and by validating that PHI is neither retained longer than necessary nor used for model training without your approval.

How does the Business Associate Agreement protect PHI?

A BAA contractually limits how PHI may be used and disclosed, mandates Security Rule controls, requires subcontractors to meet the same standards, and defines breach notification, audit, and data deletion obligations. Practically, it converts policy promises into enforceable requirements you can monitor and hold the vendor to.

Are user conversations private by default on OpenEvidence?

Default privacy settings vary by product tier and configuration. Treat prompts and files as retained unless you verify retention windows, training opt-outs, and deletion controls. Ask whether conversations are stored, who can access them, how long they persist, and whether “no training” settings apply to all subprocessors.

What should organizations consider before submitting PHI to OpenEvidence?

Ensure a signed BAA, confirm a HIPAA-eligible environment, map data flows to all subprocessors, lock down access (SSO/MFA/RBAC), configure retention and deletion, verify logging and export for audits, and train users on minimum necessary and de-identification. Pilot with non-PHI first to validate controls end to end.